SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Germany · Delayed Price · Currency is EUR 22.75
+0.60 (2.71%)
At close: Aug 19, 2026
ETR:1SXP Revenue
SCHOTT Pharma AG & Co. KGaA had revenue of 281.76M EUR in the quarter ending June 30, 2026, with 9.99% growth. This brings the company's revenue in the last twelve months to 1.02B, up 4.15% year-over-year. In the fiscal year ending September 30, 2025, SCHOTT Pharma AG & Co. KGaA had annual revenue of 986.21M with 3.04% growth.
Revenue (ttm)
1.02B
Revenue Growth
+4.15%
P/S Ratio
3.28
Revenue / Employee
203.28K
Employees
5,002
Market Cap
3.34B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 986.21M | 29.12M | 3.04% |
| Sep 30, 2024 | 957.09M | 58.49M | 6.51% |
| Sep 30, 2023 | 898.60M | 77.46M | 9.43% |
| Sep 30, 2022 | 821.14M | 172.48M | 26.59% |
| Sep 30, 2021 | 648.67M | 64.44M | 11.03% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.38B |
| Siemens Healthineers AG | 23.17B |
| Merck KGaA | 21.14B |
| Fresenius Medical Care AG | 19.43B |
| Drägerwerk AG & Co. KGaA | 3.57B |
| Redcare Pharmacy NV | 3.22B |
| Fielmann Group AG | 2.44B |
| Carl Zeiss Meditec AG | 2.18B |
SCHOTT Pharma AG & Co. KGaA News
- 7 days ago - SCHOTT Pharma AG & Co. KGaA Earnings Call Transcript: Q3 2026 - Transcripts
- 7 days ago - SCHOTT Pharma AG & Co. KGaA Slides: Q3 2026 - Filings
- 7 days ago - SCHOTT Pharma AG & Co. KGaA Quarterly report: Q3 2026 - Filings
- 7 weeks ago - SCHOTT Pharma AG & Co. KGaA Slides: Corporate presentation - Filings
- 2 months ago - Strengthening U.S. Pharmaceutical Supply: SCHOTT Pharma Inaugurates Expanded Vial Production in Lebanon, PA - Business Wire
- 2 months ago - SCHOTT Pharma AG & Co. KGaA Slides: Corporate presentation - Filings
- 3 months ago - SCHOTT Pharma AG & Co. KGaA Earnings Call Transcript: Q2 2026 - Transcripts
- 3 months ago - SCHOTT Pharma AG & Co. KGaA Slides: Q2 2026 - Filings